Yagi Asami, Ueda Yutaka, Ikeda Sayaka, Oka Emiko, Nakagawa Satoshi, Hiramatsu Kosuke, Komori Kumi, Ozaki Rie, Yutani Naomi, Kanamoto Saki, Taniguchi Yuki
Department of Obstetrics and Gynecology, Osaka University Graduate School of Medicine, 2-2, Yamadaoka, Yamadaoka, Suita, 565-0871, Osaka, Japan.
Sunstar Foundation, 1-35-10, Kawanishi-cho, Takatsuki, 569-1133, Osaka, Japan.
Sci Rep. 2025 Feb 12;15(1):5277. doi: 10.1038/s41598-025-86863-6.
In Japan, cancer screening is conducted under a variety of umbrellas, i.e., via population-based screening, occupational health checkups, insured medical care, and personal medical checkups. Quality control assessment of cancer screenings is conducted by national and local governments only for population-based screenings. The purpose of this study was to clarify the status of women receiving cervical and breast cancer screenings in Japan by any of these means. As a model associated with occupational screenings, we surveyed female employees and male employees' spouses of Sunstar, Inc., a Japanese subsidiary of an international corporation. The number of valid responses collected from March to July 2023 was 345. Among those who had cancer screening either regularly or irregularly, 66% (89/134) and 56% (47/84), respectively, received cervical and breast cancer screenings more frequently than every two years, the prescribed interval for population-based screening. Our survey revealed that a small number of women are routinely receiving cervical and breast cancer screenings more frequently than appropriate, suggesting a need to provide better information to screening consumers and providers on what constitutes appropriate screening schedules. Our survey also revealed that there is no governmental management entity for opportunistic screenings, so the status among female employees and male employee's spouses of a company, Sunstar, Inc. is unclear.
在日本，癌症筛查在多种框架下进行，即通过基于人群的筛查、职业健康检查、参保医疗护理以及个人体检。癌症筛查的质量控制评估仅由国家和地方政府针对基于人群的筛查开展。本研究的目的是阐明日本女性通过上述任何一种方式接受宫颈癌和乳腺癌筛查的情况。作为与职业筛查相关的一个范例，我们对一家国际公司的日本子公司Sunstar公司的女性员工及其男性员工的配偶进行了调查。2023年3月至7月收集到的有效回复数量为345份。在那些定期或不定期进行癌症筛查的人中，分别有66%（89/134）和56%（47/84）接受宫颈癌和乳腺癌筛查的频率高于基于人群筛查规定的每两年一次的间隔。我们的调查显示，有少数女性进行宫颈癌和乳腺癌筛查的频率高于适当水平，这表明有必要向筛查的消费者和提供者提供更好的信息，说明什么是适当的筛查时间表。我们的调查还显示，对于机会性筛查没有政府管理实体，因此Sunstar公司女性员工及其男性员工配偶的情况尚不清楚。
